TY  - BOOK
AU  - Mishra,Vikas
TI  - Infectious Diseases: an evidence based approach
SN  - 1773618377
PY  - 2019///
CY  - Ashland
PB  - Delve Publishing
KW  - Communicable diseases
N1  - Lessons From The History of Combination Therapy; Cover; Half Title Page; Title Page; Copyright Page; Declaration; About the Editor; Table of Contents; List of Contributors; List of Abbreviations; Preface; SECTION I INFECTION CONTROL AND USE OF ANTIBIOTICS; Chapter 1 Antibiotic Control of Antibiotic Resistance in Hospitals: A Simulation Study; Abstract; Background; Methods; Results; Discussion; Appendix: Explanation For The Differences Between Deterministic and Stochastic Simulation Results; Acknowledgements; Authors' Contributions; References; Chapter 2 Hospital-and Patient-Related Factors Associated With Differences in Hospital Antibiotic Use: Analysis of National Surveillance ResultsAbstract; Background; Methods; Results; Discussion; Conclusions; Acknowledgements; Authors' Contributions; References; Chapter 3 Prevention and Control of Antimicrobial Resistant Healthcare-Associated Infections: The Microbiology Laboratory Rocks!; Introdution; Tasks of The Microbiology Laboratory; Antibiotic Stewardship Programs; Issues on The Laboratory Efficacy; Conclusion; Author Contributions; References; Chapter 4 Global Increase and Geographic Convergence in Antibiotic Consumption Between 2000 And 2015Abstract; Methods; Results; Discussion; Acknowledgments; References; Chapter 5 Antibiotic Use and Clinical Outcomes in the Acute Setting Under Management by an Infectious Diseases Acute Physician Versus Other Clinical Teams: A Cohort Study; Abstract; Introduction; Methods; Results; Discussion; Acknowledgments; References; Chapter 6 Evaluation of Risk Factors for Antibiotic Resistance In Patients With Nosocomial Infections Caused Bypseudomonas Aeruginosa; Abstract; Introduction; Material and MethodsResults; Discussion; Conclusion; Authors' Contributions; References; Chapter 7 How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?; Abstract; Minireview; Mechanisms by Which Existing Vaccines Can Address the Amr Problem; Prospects For Gaining Similar Benefits With New or Improved Vaccines Against Other Amr Pathogens; Targeting Vaccines Selectively to Resistant Clones or Directly Against Factors Mediating Resistance: A Novel Approach to Controlling AMR; Synergy Between Passive or Vaccine-Induced Antibodies and Antimicrobials in Treating or Preventing Amr InfectionsResearch and Policy Needs; Conclusion; References; SECTION II TB INFECTION; Chapter 8 Origins of Combination Therapy For Tuberculosis: Lessons For Future Antimicrobial Development and Application; Abstract; Introduction; History of Antibiotic Development From Penicillin to Streptomycin; History of Chemotherapeutic Development From Arsphenamine to PAS; The First Combined Antimicrobial Regimen; The Path to Modern Antimicrobial Therapy for Tuberculosis
UR  - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=2014020
ER  -